BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help
Search Results
Documents 1-2 out of 2 found
  Current Search:  renagel: 2     
HTML
100%
EARNINGS PREVIEW: US Biotechs Seen Posting Solid 3Q Sales
Genentech Inc.(DNA) - reports Oct.

14 Wall Street Expectations: Analysts project Genentech to report earnings, excluding items, of 89 cents a share on revenue of $3.36 billion, according to Thomson Reuters.

A year ago, the company earned...

Morningstar.com:  Oct 8 2008 5:05PM
Matching: renagel 		Find similar documents
HTML
100%
Genzyme Beats, Holds to Lowered Guidance
Genzyme GENZ But Wall Street found untouched guidance and an overhang in the larger scale production of Pompe disease treatment Myozyme to be offsetting.

Shares of the Cambridge, Mass.-based biotechnology company, which specializes in...

TheStreet.com:  Jul 23 2008 3:51PM
Matching: renagel 		Find similar documents
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.